SCHEMBL19722319

SCHEMBL19722319

C=C(CO)C(=O)OCCCc1ccc(OCC2CCC(CCCCC)CC2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ITGB3 P05106 5/20 0.41
▸ ITGA2B P08514 5/20 0.41
▸ MEN1 O00255 1/20 0.38
▸ USP2 O75604 1/20 0.38
▸ ALDH1A1 P00352 1/20 0.38
▸ LMNA P02545 1/20 0.38
▸ CYP3A4 P08684 1/20 0.38
▸ MAPK1 P28482 1/20 0.38
▸ CASP1 P29466 1/20 0.38
▸ KMT2A Q03164 1/20 0.38
▸ SMN1; SMN2 Q16637 1/20 0.38
▸ SLCO1B3 Q9NPD5 1/20 0.38
▸ SLCO1B1 Q9Y6L6 1/20 0.38
▸ ACACB O00763 2/20 0.38
▸ THRB P10828 1/20 0.37
▸ ITGAV P06756 1/20 0.37
▸ CHRM2 P08172 1/20 0.37
▸ SLC6A4 P31645 1/20 0.37
▸ PARP15 Q460N3 1/20 0.37
▸ PARP10 Q53GL7 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19722193 0.90 ITGB3 (0.39) ITGB3ITGA2BACACBTHRBITGAV
SCHEMBL19722588 0.89 S1PR1 (0.42) ITGB3ITGA2BPARP15PARP10S1PR1
SCHEMBL19722362 0.86 F2 (0.43) ITGB3ITGA2BMEN1USP2ALDH1A1
SCHEMBL19721820 0.86 SPHK1 (0.44) ITGB3ITGA2BALDH1A1LMNA
SCHEMBL19722051 0.85 SPHK1 (0.43) ITGB3ITGA2BALDH1A1LMNA
SCHEMBL19722554 0.85 SPHK1 (0.43) ITGB3ITGA2BALDH1A1LMNA
SCHEMBL19722363 0.85 ITGB3 (0.35) ITGB3ITGA2BMEN1USP2ALDH1A1
SCHEMBL19722414 0.83 SPHK1 (0.42) ITGB3ITGA2BALDH1A1LMNA
SCHEMBL19722155 0.83 SPHK1 (0.42) ALDH1A1LMNA
SCHEMBL19755066 0.83 SPHK1 (0.42) ITGB3ITGA2BALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210214615-A1 LIQUID CRYSTAL DISPLAY DEVICE AND DISPLAY UNIT JNC CORPORATION (JP) 2021-07-15 — — US disclosed
EP-3257839-B1 POLYMERIZABLE POLAR COMPOUND, LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL DISPLAY DEVICE JNC CORP (JP) 2019-09-04 — — EP disclosed
US-10392339-B2 Polymerizable polar compound, liquid crystal composition, and liquid crystal display element JNC CORPORATION (JP) 2019-08-27 — — US disclosed
WO-2018025974-A1 LIQUID-CRYSTAL DISPLAY ELEMENT AND DISPLAY DEVICE JNC株式会社 2018-02-08 — — WO disclosed
US-20170369418-A1 POLYMERIZABLE POLAR COMPOUND, LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL DISPLAY ELEMENT JNC CORPORATION (JP) 2017-12-28 — — US disclosed
EP-3257839-A1 POLYMERIZABLE POLAR COMPOUND, LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL DISPLAY ELEMENT JNC Corporation (JP) 2017-12-20 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10392339-B2 Polymerizable polar compound, liquid crystal composition, and liquid crystal display element SP1, HVCN1, CXCR1 ITGB3 2716/4885ITGA2B 3852/4885MEN1 90/4885
US-20170369418-A1 POLYMERIZABLE POLAR COMPOUND, LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL DISPLAY ELEMENT SP1, SPIN1, SAV1 ITGB3 3454/4885ITGA2B 3222/4885MEN1 195/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback